| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 32,773 | 26,850 | ||
| Available-for-sale marketable securities | 151,341 | 178,143 | ||
| Accounts receivable | 960 | 873 | ||
| Prepaid expenses and other current assets | 4,746 | 5,815 | ||
| Total current assets | 189,820 | 211,681 | ||
| Property and equipment, net | 13,895 | 15,113 | ||
| Long-term investments | 2,154 | 2,154 | ||
| Operating lease right-of-use assets | 36,011 | 37,283 | ||
| Other assets | 809 | 805 | ||
| Restricted cash | 5,248 | 5,248 | ||
| Total assets | 247,937 | 272,284 | ||
| Accounts payable | 1,215 | 2,891 | ||
| Accrued expenses and other current liabilities | 9,897 | 5,924 | ||
| Current portion of operating lease liabilities | 5,571 | 5,508 | ||
| Deferred revenue | 12,900 | 18,942 | ||
| Total current liabilities | 29,583 | 33,265 | ||
| Non-current portion of operating lease liabilities | 36,092 | 37,482 | ||
| Deferred revenue, non-current | 1,896 | 3,553 | ||
| Other non-current liabilities | 1,919 | 2,153 | ||
| Total liabilities | 69,490 | 76,453 | ||
| Common stock 0.0001 par value 500,000,000 shares authorized 37,546,751 and 37,418,470 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 4 | 4 | ||
| Additional paid-in-capital | 466,414 | 463,404 | ||
| Accumulated other comprehensive income | 371 | 372 | ||
| Accumulated deficit | -288,342 | -267,949 | ||
| Total stockholders' equity | 178,447 | 195,831 | ||
| Total liabilities and stockholders' equity | 247,937 | 272,284 | ||
Metagenomi, Inc. (MGX)
Metagenomi, Inc. (MGX)